The Place of Radiotherapy in the Management of Desmoid Tumors
International Research Journal of Oncology,
The management of desmoid tumors has undergone changes in recent years including active surveillance for asymptomatic and non-progressive tumors. The place of radiotherapy is contested due to significant toxicity. Radiation therapy is offered as an alternative to surgery for tumors that are unresectable or whose removal exposes functional or life damage.
In view of the high recurrence potential, radiotherapy should also be discussed after surgery for desmoid tumors. Irradiation has shown its benefit in terms of local control for tumors whose excision is incomplete. Its place after full surgery is controversial.
Through this review of the literature, we propose to support the indications for radiotherapy in the management of desmoid tumors and to present its technical aspects.
How to Cite
Montagliani L, Duverger V. Desmoid tumors. Journal of Surgery. 2008;145(1): 20-26.
Salas S, Chibon F. Biology and signaling pathways involved in the oncogenesis of desmoid tumors. Cancer Bulletin. 2020; 107(3):346-351.
Janssen ML, van Broekhoven DL, Cates JM, Bramer WM, Nuyttens JJ, Gronchi A, et al. Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis. Br J Surg. 2017;104(4):347e357.
Hong AM, Jones D, Boyle R, Stalley P. Radiation therapy as an alternative treatment for desmoid fibromatosis. Clinical Oncology. 2018;1-4.
Nuyttens JJ, Rust PF, Thomas CR Jr, et al. Surgery versus radiation therapy for patients withaggressivefibromatosis or desmoidtumors: A comparative review of 22 articles. Cancer. 2000;88:1517-1523.
Bonvalot S, Rimareix F, Paumier A, Roberti E, Bouzaiene H, Le Péchoux C. What is new in the local approach of limb sarcomas and desmoid tumours?. Cancer Radiother. 2010;14:455-9.
Cotte E, Glehen O, Monneuse O, Cotton F, Vignal J. Desmoid tumors associated with familial adenomatous polyposis. Gastroenterol Clin Biol. 2004;28:574-581.
Acker JC, Bossen EH, Halperin EC. The management of desmoids Tumors. Int J Radiat Oncol Biol Phys. 1993;26:851-8.
Keus RB, Nout RA, Blay JY, de Jong JM, Hennig I, Saran F, et al. Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis e an EORTC STBSG and ROG study (EORTC 62991-22998). Ann Oncol. 2013;24(10):2672e2676.
Long- term outcomes for patients with desmoid fibromatosis treated with radiation Therapy: A 10-Year Update and Re-evaluation of the Role of Radiation Therapy for Younger Patients.
Andrew J Bishop, Maria A Zarzour, Ravin Ratan, Keila E Torres, Barry W Feig, Wei-Lien Wang, et al. Int J Radiation Oncol Biol Phys. 2019;XX:1-8.
Tsagozis P, Stevenson JD, Grimer R, et al. Outcome of surgery for primary and recurrent desmoid-type fibromatosis. A retrospective case series of 174 patients. Ann Med Surg (Lond). 2017;17:14-19.
Guadagnolo BA, Zagars GK, Ballo MT. Long-termoutcomes for desmoids tumors treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2008;71:41-447.
Bates JE, Morris CG, Iovino NM, et al. Radiation therapy for aggressive fibromatosis: The association between local control and age. Int Radiat Oncol Biol Phys. 2018;100:997-1003.
Wirth L, Klein A, Baur-Melnyk A, et al. Desmoid tumors of the extremity and trunk. A retrospective study of 44 patients. BMC Musculoskelet Disord. 2018; 19:2.
Kasper B, Baumgarten C, Bonvalot S, et al. On behalf of the desmoidworking group. Management of sporadicdesmoid-type fibromatosis: A European consensus approachbased on patients and professionals expertise - a sarcoma patients EuroNet (SPAEN) and European organization for research and treatment of cancer (EORTC) / Soft tissue and Bone sarcoma group (STBSG) initiative. J Cancer. 2015;51:127-136
Kasper B, Baumgarten C, Garcia J, et al. On behalf of the desmoids working group. An update on the management of sporadic desmoid-type fibromatosis: A European consensus initiative betweensarcoma patients EuroNet (SPAEN) and European organization for research and treatment of cancer (EORTC) / Soft tissue and Bone sarcoma group (STBSG). Ann Oncol. 2017;28:2399-2408.
Lev D, Kotilingam D, Wei C, Ballo MT, Zagars GK, Pisters PW, et al. Optimizing treatment of desmoid tumors. J Clin Oncol. 2007;25(13):1785-91.
Liu J, Ng D, Lee J, Stalley P, Hong A. Chest wall desmoid tumors treated with definitive radiotherapy: A plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy. Radiat Oncol. 2016;11:34.
Goy BW, Lee SP, Eilber F, Dorey F, Eckardt J, Fu Y, et al. TheRole of adjuvant radiotherapy in the treatment of resect abledesmoid tumors. Int J RadiatOncol Biol Phys. 1997;39:659–65.
Radiation-inducedun differ enciated pleomor phicsarcoma after radiation therapy for a desmoidtumor. J Di Marco, R Kaci, B Orcel, R. Nizard, J-D Laredo. Cancer / Radiotherapy. 20(1):36-38.
Abstract View: 37 times
PDF Download: 19 times